scholarly journals Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide

2021 ◽  
Vol Volume 13 ◽  
pp. 1617-1624
Author(s):  
Marii Suehiro ◽  
Yasuyuki Kojima ◽  
Masaki Takahashi ◽  
Yuka Ito ◽  
Takayuki Keira ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Antiemetic Efficacy

Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin

1994 ◽  
Vol 17 (2) ◽  
pp. 97-102 ◽  
Author(s):  
T. Conroy ◽  
P. Cappelaere ◽  
M. Fabbro ◽  
A. A. Fauser ◽  
T. A. W. Splinter ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Efficacy And Safety ◽  
Antiemetic Efficacy

scholarly journals Antiemetic efficacy of cimetidine randomized, double-blind, crossover study with dexamethasone in cancer patients receiving emetogenic chemotherapy

1991 ◽  
Vol 2 (7) ◽  
pp. 517-518 ◽  
Author(s):  
M.S. Al-Ghamdi ◽  
E.M. Ibrahim ◽  
H.Y. Al-Idrissi ◽  
A.A. Al-Khatti ◽  
A. Al-Faraj
Keyword(s):  
Crossover Study ◽  
Cancer Patients ◽  
Emetogenic Chemotherapy ◽  
Double Blind ◽  
Antiemetic Efficacy ◽  
Blind Crossover Study ◽  
Double Blind Crossover Study

Safety, Tolerability, Antiemetic Efficacy, and Pharmacokinetics of Oral Dolasetron Mesylate in Pediatric Cancer Patients Receiving Moderately to Highly Emetogenic Chemotherapy

1999 ◽  
Vol 21 (4) ◽  
pp. 274-283 ◽  
Author(s):  
Max J. Coppes ◽  
Rochelle Yanofsky ◽  
Sheila Pritchard ◽  
Jean-Marie Leclerc ◽  
Danny R. Howard ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Pediatric Cancer ◽  
Emetogenic Chemotherapy ◽  
Highly Emetogenic Chemotherapy ◽  
Antiemetic Efficacy ◽  
Pediatric Cancer Patients

Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy

2018 ◽  
Vol 18 (2) ◽  
pp. e157-e165 ◽  
Author(s):  
Satoshi Yokoyama ◽  
Satoshi Tamaru ◽  
Shinya Tamaki ◽  
Daisuke Nakanishi ◽  
Akiya Mori ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Cancer Patients ◽  
Genetic Risk ◽  
Genetic Risk Factors ◽  
Breast Cancer Patients ◽  
Factors Associated ◽  
Antiemetic Efficacy

scholarly journals Association of Abc Polymorphism with Antiemetic Efficacy in Cancer Patients Treated with Highly Emetogenic Chemotherapy

2014 ◽  
Vol 25 ◽  
pp. v87
Author(s):  
Daiki Tsuji ◽  
Yong-Il Kim ◽  
Takashi Daimon ◽  
Ryo Makuta ◽  
Chiho Homma ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Emetogenic Chemotherapy ◽  
Highly Emetogenic Chemotherapy ◽  
Antiemetic Efficacy

1580 Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy of a triple antiemetic combination in cancer patients receiving cisplatin-based chemotherapy: TRIPLE Pharmacogenomics Study

2015 ◽  
Vol 51 ◽  
pp. S231
Author(s):  
K. Suzuki ◽  
D. Tsuji ◽  
M. Yokoi ◽  
T. Daimon ◽  
M. Nakao ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Antiemetic Efficacy
Sign in / Sign up

Export Citation Format

Share Document